These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23796811)

  • 1. Cumulative life course impairment: identifying patients at risk.
    Augustin M
    Curr Probl Dermatol; 2013; 44():74-81. PubMed ID: 23796811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative life course impairment: evidence for psoriasis.
    Mattei PL; Corey KC; Kimball AB
    Curr Probl Dermatol; 2013; 44():82-90. PubMed ID: 23796812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting up a life course questionnaire.
    Sampogna F
    Curr Probl Dermatol; 2013; 44():67-73. PubMed ID: 23796810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life course impairment and quality of life over time.
    Sampogna F
    Curr Probl Dermatol; 2013; 44():47-51. PubMed ID: 23796808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course.
    Warren RB; Kleyn CE; Gulliver WP
    Br J Dermatol; 2011 May; 164 Suppl 1():1-14. PubMed ID: 21477010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative life course impairment in other chronic or recurrent dermatologic diseases.
    Ibler KS; Jemec GB
    Curr Probl Dermatol; 2013; 44():130-6. PubMed ID: 23796817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative life course impairment in melanoma and nonmelanoma skin cancer.
    Piaserico S
    Curr Probl Dermatol; 2013; 44():118-24. PubMed ID: 23796815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention and cumulative life course impairment in psoriasis: a review.
    Arancio LMH; D'Amico D; Dastoli S; Fiorella CS; Manfredini M; Moretta G; Paolino G; Levi A; Di Fino S; Zucchi B; Piaserico S
    Clin Exp Dermatol; 2024 Nov; 49(12):1525-1531. PubMed ID: 39045914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative life course impairment in patients with dermatological diseases, with a focus on psoriasis.
    Romiti R; Magalhães RF; Duarte GV
    An Bras Dermatol; 2024; 99(2):269-276. PubMed ID: 38135557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis: is the impairment to a patient's life cumulative?
    Kimball AB; Gieler U; Linder D; Sampogna F; Warren RB; Augustin M
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):989-1004. PubMed ID: 20477920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative life course impairment in vitiligo.
    Krüger C; Schallreuter KU
    Curr Probl Dermatol; 2013; 44():102-17. PubMed ID: 23796814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two key concepts in the life course approach in medicine: allostatic load and cumulative life course impairment.
    Offidani E; Tomba E; Linder MD
    Curr Probl Dermatol; 2013; 44():17-32. PubMed ID: 23796806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative life course impairment: the imprint of psoriasis on the patient's life.
    Ros S; Puig L; Carrascosa JM
    Actas Dermosifiliogr; 2014 Mar; 105(2):128-34. PubMed ID: 23668623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative life course impairment across cultures and medical systems.
    Lima XT
    Curr Probl Dermatol; 2013; 44():137-44. PubMed ID: 23796818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concept of major life-changing decisions in life course research.
    Bhatti ZU; Salek S; Finlay AY
    Curr Probl Dermatol; 2013; 44():52-66. PubMed ID: 23796809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative life course impairment in chronic wounds.
    Augustin M
    Curr Probl Dermatol; 2013; 44():125-9. PubMed ID: 23796816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life span and life course approaches to dermatological disease.
    Ryff CD
    Curr Probl Dermatol; 2013; 44():1-16. PubMed ID: 23796805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Measurement Tools to Assess Cumulative Life Course Impairment in Patients with Chronic Skin Diseases.
    Braren-von Stülpnagel CC; Augustin M; Westphal L; Sommer R
    J Eur Acad Dermatol Venereol; 2023 Feb; ():. PubMed ID: 36807404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychosocial and occupational impact of chronic skin disease.
    Hong J; Koo B; Koo J
    Dermatol Ther; 2008; 21(1):54-9. PubMed ID: 18318886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review.
    von Stülpnagel CC; Augustin M; Düpmann L; da Silva N; Sommer R
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):2166-2184. PubMed ID: 33988873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.